Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check50 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government-funding status notice, updating revision history and site status.SummaryDifference0.2%

- Check85 days agoChange DetectedA new site-wide notice about government funding lapse and NIH Clinical Center status has been added, and the page revision now shows v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page adds a Show glossary option and updates metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) along with capitalization changes.SummaryDifference0.1%

Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.